Torigen Pharmaceuticals is a leading brand in the field of advanced cancer care solutions for companion animals. Comprised of cancer researchers, veterinarians, and veterinary professionals, the company is dedicated to extending the lives of pets diagnosed with cancer. Guided by science and technology, Torigen's work is fueled by a deep passion and love for animals.

Their flagship product is an experimental autologous cancer vaccine, developed based on the research of Dr. Mark Suckow, a renowned professor and Associate Vice President of Research at the University of Kentucky. Driven by innovation, Torigen is constantly evaluating new technologies and expanding their pipeline to stay at the forefront of veterinary medicine.

The skilled team at Torigen includes Ashley Kalinauskas, the CEO and founder of the company, and Dr. Michael Lucroy, an experienced oncologist. Together, they analyze data sets, identify new therapeutic options, and manage national immuno-oncology educational programs.

Dr. Ryan Clauson, an immunologist, leads the research and development efforts, while Sean Fitzgerald, VP of Market Development, focuses on expanding Torigen's reach. Located in Farmington, CT, Torigen Pharmaceuticals is dedicated to providing the best care for pets, enabling them to lead longer and healthier lives.

Contact Torigen to learn more about their innovative cancer care solutions and order a kit for your furry companion